Compare Raja Roti Cemerlang Tbk. (BRRC) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Raja Roti Cemerlang Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Raja Roti Cemerlang Tbk. trades at Rp65 (market cap 64.65B), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 4.9× Raja Roti Cemerlang Tbk.'s market cap. Which is the better fit depends on your goals.
| BRRC | DGNS | |
|---|---|---|
Market Cap | 64.65B | 319B |
Indicative Equilibrium Price | 65 | 232 |
Indicative Equilibrium Volume | 47 | 2 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Raja Roti Cemerlang Tbk.
PT Raja Roti Cemerlang Tbk (the Company) was established based on Notarial Deed No. 5 dated September 21, 2015 of Dian Rohmah Yuniasari, S.H., M.Kn., notary in Bekasi. The Company begin its operation activities in 2015.
Read more on BRRC →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
